Trials / Completed
CompletedNCT04446325
Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 227 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Venous thrombo-embolic (VTE) rates could be high in patients with amyotrophic lateral sclerosis (ALS). Indeed, the rate of VTE in this specific population could be 7-fold higher in this population. Predictiv factors of VTE in patients with ALS are mobility reduction and neurological paralysis. However, to our knowledge, medical littérature is poor concerning VTE and ALS association. Our first aim is to define annual rate of VTE in ALS population.Then we aim to identify predictiv factors of VTE in this specific population. The studied population is Brest universitary hospital cohort of ALS patient included between 2000 and 2019.
Conditions
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2020-03-01
- Completion
- 2020-05-01
- First posted
- 2020-06-24
- Last updated
- 2020-09-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04446325. Inclusion in this directory is not an endorsement.